Back to Search
Start Over
Molecular Therapies for Inherited Retinal Diseases-Current Standing, Opportunities and Challenges.
- Source :
-
Genes [Genes (Basel)] 2019 Aug 28; Vol. 10 (9). Date of Electronic Publication: 2019 Aug 28. - Publication Year :
- 2019
-
Abstract
- Inherited retinal diseases (IRDs) are both genetically and clinically highly heterogeneous and have long been considered incurable. Following the successful development of a gene augmentation therapy for biallelic RPE65 -associated IRD, this view has changed. As a result, many different therapeutic approaches are currently being developed, in particular a large variety of molecular therapies. These are depending on the severity of the retinal degeneration, knowledge of the pathophysiological mechanism underlying each subtype of IRD, and the therapeutic target molecule. DNA therapies include approaches such as gene augmentation therapy, genome editing and optogenetics. For some genetic subtypes of IRD, RNA therapies and compound therapies have also shown considerable therapeutic potential. In this review, we summarize the current state-of-the-art of various therapeutic approaches, including the pros and cons of each strategy, and outline the future challenges that lie ahead in the combat against IRDs.
Details
- Language :
- English
- ISSN :
- 2073-4425
- Volume :
- 10
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- Genes
- Publication Type :
- Academic Journal
- Accession number :
- 31466352
- Full Text :
- https://doi.org/10.3390/genes10090654